Published in Br J Dermatol on December 01, 1997
Recurrent cutaneous necrotizing eosinophilic vasculitis: a case report and review of the literature. Diagn Pathol (2013) 0.89
Wells Syndrome with Multiorgan Involvement Mimicking Hypereosinophilic Syndrome. Case Rep Dermatol (2009) 0.85
Idiopathic Hypereosinophilic Syndrome With Cutaneous Manifestations and Flame Figures: A Spectrum of Eosinophilic Dermatoses Whose Features Overlap With Wells' Syndrome. Am J Dermatopathol (2015) 0.75
Hypereosinophilic syndrome: cutaneous involvement as the sole manifestation. Indian J Dermatol (2011) 0.75
Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology (2008) 5.31
Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med (1994) 3.11
Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation (1995) 2.25
Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications. Br J Dermatol (2001) 2.05
Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut (2005) 1.95
The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol (1994) 1.94
Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol (2012) 1.78
Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene. J Pathol (2008) 1.74
31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation (1992) 1.71
Oxygen in acute and chronic wound healing. Br J Dermatol (2010) 1.56
[Psoriatic onycho-pachydermo- periostitis]. Z Rheumatol (2002) 1.56
[Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. Hautarzt (1990) 1.54
Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease. Eur Heart J (2001) 1.53
The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction. Eur Heart J (2001) 1.52
A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol (2010) 1.45
Malignant germ cell tumor of the contralateral testis after radiotherapy for testicular intraepithelial neoplasia. J Urol (2000) 1.45
Metastatic signet-ring cell melanoma in a patient with an unknown primary tumor. Histologic, immunohistochemical, and ultrastructural findings. J Am Acad Dermatol (1992) 1.43
Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum. Lancet (1997) 1.43
Cutaneous pseudolymphoma induced by Cimicifuga racemosa. Dermatology (2007) 1.42
Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc Res (1998) 1.41
Ataxia-telangiectasia (Louis-Bar syndrome) associated with ulcerating necrobiosis lipoidica. J Am Acad Dermatol (1994) 1.40
Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation (1997) 1.40
Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. Dermatology (1995) 1.40
Granuloma pyogenicum as a complication of flashlamp-pumped pulsed dye laser. Dermatology (1994) 1.39
Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol (2004) 1.39
[CO(2) laser vaporisation of actinic cheilitis]. Hautarzt (1999) 1.38
Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem (1999) 1.33
Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer (1999) 1.33
Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res (1998) 1.29
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens (1998) 1.28
Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab (2000) 1.25
Indocyanine green: intracellular uptake and phototherapeutic effects in vitro. J Photochem Photobiol B (1997) 1.22
Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol (2000) 1.22
Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands. Arch Dermatol Res (1980) 1.22
Skin ageing. J Eur Acad Dermatol Venereol (2011) 1.21
Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ (1998) 1.19
Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Am Acad Dermatol (1987) 1.17
Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy (2009) 1.16
Evidence for a vasopressin system in the rat heart. Circ Res (1999) 1.15
[Her2 testing in gastric cancer. What is different in comparison to breast cancer?]. Pathologe (2010) 1.14
Simultaneous occurrence of folliculitis decalvans capillitii in identical twins. Br J Dermatol (2000) 1.13
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib. Lung Cancer (2013) 1.13
Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension (1998) 1.12
Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens (2000) 1.12
Cytokines, chemokines and growth factors in wound healing. J Eur Acad Dermatol Venereol (2011) 1.11
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum (2001) 1.11
Comparative coronary anatomy in six twin pairs with coronary artery disease. Heart (2000) 1.11
Plasma applications in medicine with a special focus on dermatology. J Eur Acad Dermatol Venereol (2011) 1.11
Diuretic treatment and diuretic resistance in heart failure. Am J Med (1999) 1.10
The associations of body size and body composition with left ventricular mass: impacts for indexation in adults. J Am Coll Cardiol (1998) 1.09
Indocyanine green (ICG) and laser irradiation induce photooxidation. Arch Dermatol Res (2000) 1.07
Fast and effective skin ablation with an Er:YAG laser: determination of ablation rates and thermal damage zones. Lasers Surg Med (1997) 1.06
Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin Cancer Res (1998) 1.06
Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int J Colorectal Dis (2006) 1.06
Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses. Br J Dermatol (2008) 1.06
Cloning and expression of the murine sws/NTE gene. Mech Dev (2000) 1.05
Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes. Exp Dermatol (2003) 1.03
Increased expression of connexin 43 in the overactive neurogenic detrusor. Eur Urol (2004) 1.03
Q-switch laser and tattoo pigments: first results of the chemical and photophysical analysis of 41 compounds. Lasers Surg Med (2000) 1.02
Treatment of diffuse plane xanthoma of the face with the Erbium:YAG laser. Arch Dermatol (2001) 1.02
Photostability and thermal stability of indocyanine green. J Photochem Photobiol B (1998) 1.01
PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features. Histopathology (2005) 1.01
Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading. Am J Pathol (1989) 1.01
Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol (1994) 1.01
Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol (2004) 0.99
c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol (2007) 0.99
Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany. Digestion (2006) 0.99
Embryonic lethality caused by apoptosis during gastrulation in mice lacking the gene of the ADP-ribosylation factor-related protein 1. Mol Cell Biol (2002) 0.98
Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases. Lasers Surg Med (2001) 0.98
FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis. Br J Dermatol (2012) 0.97
Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma. Br J Cancer (1998) 0.97
[Erythema scarlatiniforme desquamativum recidivans localisatum]. Hautarzt (1985) 0.97
In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers. J Pathol (1999) 0.96
Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension (1995) 0.96
Ehlers-Danlos type VIII. Review of the literature. Clin Oral Investig (2000) 0.96
Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res (2001) 0.96
Inhibition of synthesis of endothelium-derived nitric oxide in conscious dogs. Hemodynamic, renal, and hormonal effects. Am J Hypertens (1992) 0.96
Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur Urol (2004) 0.95
Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol (1998) 0.95
Expression of immediate early genes after cardioplegic arrest and reperfusion. Ann Thorac Surg (1997) 0.95
Long-term dermoscopic follow-up of melanocytic naevi: clinical outcome and patient compliance. Br J Dermatol (2003) 0.94
Marked suppression of renin levels by beta-receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade. J Intern Med (2001) 0.94
[Porokeratosis Mibelli gigantea: case report and literature review]. Hautarzt (1999) 0.94
Neodymium-YAG laser therapy for vascular lesions. J Am Acad Dermatol (1986) 0.94
MIA as a reliable tumor marker in the serum of patients with malignant melanoma. Anticancer Res (2001) 0.94
Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J (1998) 0.94
Gastric carcinoma metastatic to the site of a congenital melanocytic nevus. J Am Acad Dermatol (1993) 0.93
Comparison between a clinical activity index (Harvey-Bradshaw-Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohn's disease. Eur J Radiol (2011) 0.93
Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions. Histopathology (2006) 0.93
Indocyanine green-augmented diode laser treatment of port-wine stains: clinical and histological evidence for a new treatment option from a randomized controlled trial. Br J Dermatol (2012) 0.93